New pill aims to shrink liver tumors in patients with advanced disease
Disease control
Recruiting now
This study tests an experimental pill called TTI-101 in people with advanced liver cancer that cannot be removed by surgery. Some participants receive TTI-101 alone, while others get it combined with standard immunotherapy drugs. The main goals are to check safety and see if the …
Phase: PHASE1, PHASE2 • Sponsor: Tvardi Therapeutics, Incorporated • Aim: Disease control
Last updated May 04, 2026 16:18 UTC